Evidence map›Paper›PMID 33592038›Full record

ArticlePloS one2021

The expression in plants of an engineered VP2 protein of Infectious Bursal Disease Virus induces formation of structurally heterogeneous particles that protect from a very virulent viral strain.

Carla Marusic, Charifa Drissi Touzani, Alessio Bortolami, Marcello Donini, Claudia Zanardello, Chiara Lico, Emile Rage, Siham Fellahi, Mohammed El Houadfi, Calogero Terregino and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Carla MarusicLaboratory of Biotechnology, ENEA Casaccia Research Center, Rome, Italy.ORCID 0000-0002-2789-7597
Charifa Drissi TouzaniAvian Pathology Unit, Pathology and Veterinary Public Health Department, Agronomy and Veterinary Institute Hassan II, Rabat, Morocco.
Alessio BortolamiSpecialized Virology and Experimental Research Department Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.
Marcello DoniniLaboratory of Biotechnology, ENEA Casaccia Research Center, Rome, Italy.
Claudia ZanardelloDiagnostic Services, Histopathology, Parasitology Department, Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.
Chiara LicoLaboratory of Biotechnology, ENEA Casaccia Research Center, Rome, Italy.ORCID 0000-0001-8475-5141
Emile RageLaboratory of Biotechnology, ENEA Casaccia Research Center, Rome, Italy.
Siham FellahiAvian Pathology Unit, Pathology and Veterinary Public Health Department, Agronomy and Veterinary Institute Hassan II, Rabat, Morocco.
Mohammed El HouadfiAvian Pathology Unit, Pathology and Veterinary Public Health Department, Agronomy and Veterinary Institute Hassan II, Rabat, Morocco.
Calogero TerreginoSpecialized Virology and Experimental Research Department Istituto Zooprofilattico Sperimentale delle Venezie, Legnaro, Italy.
Selene BaschieriLaboratory of Biotechnology, ENEA Casaccia Research Center, Rome, Italy.
National Agency for New Technologies, Energy and Sustainable Economic Development · ITInstitut Agronomique et Vétérinaire Hassan II · MAIstituto Zooprofilattico Sperimentale delle Venezie · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious Bursal Disease Virus (IBDV), the etiological agent of Gumboro disease, causes mortality and immunosuppression in chickens and major losses to poultry industry worldwide. The IBDV major capsid protein VP2 is considered the best candidate for the production of novel subunit vaccines. This structural protein contains the major conformational epitopes responsible for the induction of IBDV neutralizing antibodies in chickens and has been demonstrated able to form supramolecular structures in yeast and insect cells. The aim of this study was to express an engineered version of the VP2 protein (His-pVP2) to verify its ability to self-assemble into virus-like particles in plants. The recombinant VP2 was transiently expressed by agroinfiltration in Nicotiana benthamiana and transmission electron microscopy of sucrose density gradient fractions revealed the presence of a mixed population of differently shaped particles ranging from spherical capsids, with a diameter between ~25 and ~70 nm, to tubular structures, with variable length (from 100 to 400 nm). The recombinant VP2-based particles when used for the intramuscular immunization of specific-pathogen-free chicks resulted able to induce the production of anti-IBDV specific antibodies at titers comparable to those induced by a commercial vaccine. Moreover, all the immunized birds survived to the challenge with a Moroccan very virulent IBDV strain with no major histomorphological alterations of the Bursa of Fabricius, similarly to what obtained with the commercial inactivated vaccine.

Indexed as

AnimalsBlotting, WesternCapsidChickensEnzyme-Linked Immunosorbent AssayInfectious bursal disease virusMicroscopy, Electron, TransmissionNicotianaRecombinant ProteinsVirulenceRecombinant Proteins

Identifiers

PMID33592038
PMCPMC7886152
OpenAlexW3129939733

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.